MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$223,123,000
Accretion of discount on
investments, net
$7,297,000
Interest and other
income, net
$3,218,000
Loss from operations
-$231,747,000
Interest expense
$1,891,000
Total operating
expenses
$231,747,000
Research and development
$142,015,000
General and
administrative
$86,501,000
Restructuring
$3,231,000
Back
Back
Income Statement
source: myfinsight.com
ROCKET PHARMACEUTICALS, INC. (RCKTW)
ROCKET PHARMACEUTICALS, INC. (RCKTW)